Daily Stock List
Circle Star Energy Corp. (CRCL)
OTC Markets Group, Streetwise Reports, Vantage Wire, and Greenbackers reported earlier on Circle Star Energy Corp. (CRCL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Circle Star Energy Corp. involves in the acquisition, development, and exploration of oil and natural gas properties in the U.S. The Company’s assets include producing and non-producing oil and gas mineral interests, royalty interests, and non-operated working interests located throughout the western south-central states. The Company was formerly known as Digital Valleys Corp. It changed its name to Circle Star Energy Corp. in July of 2011. The Company’s shares trade on the OTCQB. Circle Star Energy is headquartered in Fort Worth, Texas.
The Company’s chief goal is to increase its net asset value and cash flow through acquisitions, exploration, development, and exploitation of oil and gas properties. Its growth strategy’s four key components are identification and acquisition of strategic assets; utilization of strategic partners; cost effective implementation of operations, and increasing cash flows from existing properties. In Texas, Circle Star Energy owns royalty, non-operated working interests and mineral interests in certain oil and gas properties.
It has contracted to acquire major oil and gas prospective interests in different townships of western Kansas. The play’s principal targets are Mississippian and Pennsylvanian in geologic age. Circle Star is working to acquire key blocks of acreage via the identification of certain key parameters. These include an understanding and interpretation of reservoir closeology and analogous “show wells,” plus extensive reprocessing of seismic lines in combination with the use of conventional and unconventional subsurface exploration.
Circle Star Energy’s producing areas include Hilltop Bossier Field (Robertson County, Texas) – Deep Bossier; Madisonville Woodbine Field (Madison/Grimes, County, Texas) – Woodbine; Pearsall Field (Dimmit/Zavala County, Texas) – Austin Chalk , Eagle Ford Shale; and Permian Basin (Scurry/Crane/Glasscock et. al. County, Texas) – Wolfcamp, Clearfork, Spraberry, Fusselman, Cline Shale.
The Company provided an update in March 2013 concerning its first operated well in Trego County, Kansas. Circle Star owns a 25 percent working interest (WI) and a 20 percent net revenue interest (NRI) until payout and will convert to a 43.75 percent WI and a 35 percent NRI after payout in the Lynd 36-1 well.
The Lynd 36-1 was drilled to approximately 4,100 feet total depth. The well was previously completed in the Marmaton formation where around 12 feet of net pay zone was encountered. The 36-1 was put on pump with initial daily oil rates of 20-25 barrels of oil per day.
Circle Star Energy Corp. (CRCL), closed Thursday's trading session at $0.005, down 33.33%, on 200 volume with 1 trade. The average volume for the last 60 days is 52,047 and the stock's 52-week low/high is $0.0022/$0.035.
TransAKT Ltd. (TAKD)
PREPUMP STOCKS, Damn Good Penny Picks, Penny Stock Newsletter, Penny Picks, PennyStocks24, TheMicrocapNews, BullFreak, VIP Penny Stocks, StockRunway, FatCat Stocks, Top Best Pennystocks, and OTCEquity reported earlier on TransAKT Ltd. (TAKD), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.
TransAKT Ltd. is a manufacturer of highly innovative agricultural equipment used to grow a large array of vegetables and fruit using simulated sunlight from LED lamps in a proprietary hydroponic system. Furthermore, the Company is an international distributor of LED lighting products centered on serving the fastest growing market of commercial, hospitality, and outdoor lighting. The Company's global corporate management team is based in Las Vegas, Nevada; Calgary, Alberta; and Taipei, Taiwan.
TransAKT’ dedication is to helping business owners in protecting the environment by way of superior energy efficiency - replacing current non-energy-efficient light sources with energy-efficient light sources.
TransAKT’s wholly-owned subsidiary is Vegfab. Vegfab’s product line includes systems for commercial production and a home growing system that enables families to grow safe and clean fruit and vegetables in their homes. Vegfab Agriculture Technology Co., Ltd. was established in 2010 by a team of ecologically minded semiconductor specialists knowledgeable about LED materials.
TransAKT is concentrating on eliminating the use of chemical fertilizers and pesticides through the use of the latest hydroponic agricultural technology and pure nutrients. The nutrient solutions used in production with the Company’s hydroponic systems leave no heavy metal and chemical residues.
The Company's vegetable production factory in Yangmei City, Taiwan is the only mass production facility for vegetables in Taiwan. This facility uses innovative technology to produce exceptional yields from a very small space. Production is extremely efficient via the use of simulated sunlight from LED lamps, up to 85 percent automated.
Recently, TransAKT announced that it entered into a partnership with Taiwan Flora Seed International Co. Ltd. Taiwan Flora is an agricultural technology solution provider. It supplies finished products, training, as well as assistance to customers to setup greenhouse facilities and to successfully market their products.
Mr. James Wu, TransAKT Chairman, said, "We are committed to providing the safest and cleanest fruits and vegetables through the use of our latest hydroponic agricultural technology. Through our partnership with Taiwan Flora we're excited to be able to offer premium quality orchids and flowers all over the world. I expect that our combined expertise in agricultural technology will ensure that TransAKT is profitable in 2015."
TransAKT Ltd. (TAKD), closed Thursday's trading session at $0.078, even for the day. The average volume for the last 60 days is 44,002 and the stock's 52-week low/high is $0.045/$0.14.
SmartMetric, Inc. (SMME)
Wall Street Resources and SmallCapFinancialWire reported on SmartMetric, Inc. (SMME), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed SmartMetric, Inc. has added a fingerprint scanner built inside EMV payment credit and debit chip cards. Therefore, this creates a second layer biometric authentication protection in defending against card fraud. The Company is now marketing its technology to card issuing financial institutions globally. SmartMetric has its headquarters In Las Vegas, Nevada. Its engineering office is in Tel-Aviv Israel. The Company’s development office is in Argentina and it has an office in Melbourne, Australia for Asia Pacific markets.
The SmartMetric developed in card biometric identification and activation system employs a SmartMetric developed ultra-miniature fingerprint reader. This reader stores and reads an individual’s fingerprint. The card user's fingerprint is stored inside the card. It never travels across networks or is never stored on a central computer. It cannot be hacked by number and password generators commonly used by today's card fraudsters - unlike a PIN or password.
SmartMetric has created a security solution replacing the reliance on card PIN's with a person’s fingerprint. Built inside the payments card is a totally functional fingerprint reader. Upon a customer touching the sensor, it reads the person’s fingerprint and subsequently, upon a match, activates the cards EMV chip. If there is no match there is no card activation. It is user-friendly and works with existing EMVE systems.
The SmartMetric Biometric Vault Card has an internal processor and its own computer operating system for standalone on-card processing. It comes standard with 8GB of memory and can release cards with up to 128 GB of memory. Within the card is a miniature power management system, which handles the re-charging of the cards internal battery.
With the biometric protected vault card, an individual using their fingerprint to lock and unlock their own biometric protected stored value card provides safety, discrete portability, and a real time main street payments card. The card will work on standard ATM's worldwide. SmartMetric is preparing to start mass production in Q1 2015 with major financial institutions worldwide already expressing interest in using the Company’s biometric security solution.
The Company also offers its MedicalKeyring™. It is a product that uses the world's first smallest miniature fingerprint scanner, engineered and developed by SmartMetric. This enables a person to carry their complete medical files with them. All the files are protected by the file owner's biometric fingerprint.
SmartMetric, Inc. (SMME), closed Thursday's trading session at $0.059, up 7.27%, on 3,480 volume with 1 trade. The average volume for the last 60 days is 79,623 and the stock's 52-week low/high is $0.03/$0.245.
Terra Tech Corp. (TRTC)
SmallCapVoice, Market Authority, Penny Stocks24, Penny Stock, and Center Stage Stocks reported earlier on Terra Tech Corp. (TRTC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Terra Tech Corp., via its wholly-owned subsidiary GrowOp Technology, specializes in controlled environment agricultural technologies. Terra Tech integrates best-of-breed hydroponic equipment with proprietary software and hardware to provide sustainable solutions for indoor agriculture enterprises and home practitioners. The Company works closely with expert horticulturists, engineers, as well as plant scientists to develop and manufacture advanced proprietary products for the emerging urban agricultural industry and individual hobbyists. The Company operates in two distinct markets. One is Commercial Agriculture; the other is Retail Agriculture. Terra Tech has its corporate office in Irvine, California.
Regarding Commercial Agriculture, Terra Tech works with customers to help design, develop, and manufacture cultivation systems that maximize space and reduce energy costs. The Company offers rooftop/vertical hydroponic and aeroponic systems to custom designed greenhouse management systems.
Regarding Retail Agriculture, Terra Tech, through GrowOp Technology, designs and manufactures an advanced and affordable line of horticulture equipment. GrowOp Technology operates out of its warehouse facility in Oakland, California.
In addition Terra Tech concentrates on medical cannabis cultivation technology. The Company’s products include Commercial Hydroponic and Aeroponic Systems with 'ADS' Automated Dosing Systems; Digital Atmospheric Controllers: Lighting, Humidity, C02 and more, and Commercial Greenhouse Manufacturing.
By way of its wholly-owned subsidiary Edible Garden, Terra Tech cultivates a premier brand of local and sustainably grown hydroponic produce. This produce sells through leading grocery stores throughout Massachusetts, New Hampshire, New Jersey, New York, Delaware, Maryland, Connecticut, Pennsylvania, Maine, Indiana, and Ohio.
Terra Tech announced this past August that its subsidiaries MediFarm, MediFarm I and MediFarm II submitted applications to operate Medical Marijuana Enterprises (MME) to the state of Nevada. Terra Tech has already received a special use permit for a cultivation and production facility in Clark County, Nevada. It also submitted its applications for a special use permit and compliance permit to the City of Las Vegas, Nevada.
Recently, the Company announced that it placed its supercritical CO2 cannabinoid extraction facility into production. Terra Tech announced that it completed testing and formulating compounds at its cannabinoid extraction facility in Northern California. The Company is currently moving into production. It will be producing an assortment of oils, waxes, and other mediums of concentrated cannabinoids
Last week, Terra Tech provided an update on its Nevada Medical Cannabis efforts. It recently announced that MediFarm, MediFarm I, and MediFarm II, have all received provisional certificates from the State of Nevada in each local jurisdiction where they applied for a Medical Marijuana Establishment license. Together, these subsidiaries were issued 4 Dispensary provisional certificates, 2 Cultivation provisional certificates, as well as 2 Production provisional certificates spanning Northern and Southern Nevada.
Terra Tech Corp. (TRTC), closed Thursday's trading session at $0.268, down 0.92%, on 1,873,683 volume with 436 trades. The average volume for the last 60 days is 1,282,618 and the stock's 52-week low/high is $0.21/$1.42.
Casey Container Corp. (CSEY)
ThePUMPTracker, StockBomb.com, PennyStockLocks.com, StockLockandLoad, Stockhunter.us, StockRockandRoll, HEROSTOCKS, VIP STOCK ALERTS, Stock Brain, and Liquid Pennies reported previously on Casey Container Corp. (CSEY), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
A Nevada corporation, Casey Container Corp. entered into an Additive Supply and License Agreement in November of 2009 with Bio-Tec Environmental, developer of the innovative EcoPure® technology. With this agreement the Company now has the unique ability to offer a ground-breaking biodegradable PET plastic packaging solution that is Food and Drug Administration (FDA) compliant.
Casey Container’s shares trade on the OTC Markets’ OTCQB. Founded in 2006, the Company has its corporate headquarters in Scottsdale, Arizona. The Company was previously known as Sawadee Ventures, Inc. It changed its name to Casey Container Corp. in January of 2010.
Casey Container can design and custom manufacture biodegradable PET plastic pre-forms, which become PET plastic containers, including bottles for water or other beverage products. Its dedication is to developing container products that meet the demands of its clients while addressing today's most fundamental environmental issues regarding the proliferation of plastics. Casey Container offers biodegradable plastic packaging solutions using the revolutionary science of EcoPure® technology. Casey Container works with Bio-Tec Environmental, developer of the EcoPure® technology. The Company is still in its development stage.
Moreover, earlier this month, Casey Container announced that its management reached a Letter of Understanding for the acquisition of a new social information network technology, which it plans to use to launch web and mobile applications with extensive international appeal. The technology represents a breakthrough in common information networks through allowing individuals and groups to search, bookmark, as well as share all forms of digital content, both privately and publicly, based on their own or shared interests.
The Company’s intention is to utilize this proprietary technology as the mainstay of a new leading information network that can combine the most commonly used functions of search and social media interaction in a single website online and across all mobile media platforms. This includes smart phones and tablets.
Casey Container Corp. (CSEY), closed Thursday's trading session at $0.03, up 7.14%, on 30,400 volume with 2 trades. The average volume for the last 60 days is 9,099 and the stock's 52-week low/high is $0.0119/$0.11.
ADM Tronics Unlimited, Inc. (ADMT)
OTC Markets Group, TheMicrocapNews, The Stock Psycho, Top Gun, Mega Stock Pick, Penny Stock Fever, and Monster OTC reported on ADM Tronics Unlimited, Inc. (ADMT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
ADM Tronics Unlimited, Inc. is a technology based developer and manufacturer of innovative, environmentally safe, health and life-enhancing technologies and products. The Company’s business segments are Proprietary Electronic Medical Devices; Eco-Friendly, Safe, Water-Based Formulations; and, Design, Engineering, Regulatory and Manufacturing Services. ADM Tronics is based in Northvale, New Jersey and the Company’s shares trade on the OTCQB.
ADM Tronics’ core competency is its ability to conceptualize a technology, bring it through development into manufacturing and commercialization, and all in-house. The Company has a multi-disciplinary team of engineers, researchers and technologists. They use advanced technology infrastructure, including 3-D solid prototyping, precision instrumentation and specialized software and peripherals for the research, development and commercialization of diversified technologies.
ADM Tronics’ diversified product areas include water-based industrial chemical solutions, non-invasive electronic therapy technology, electronic development and production, water-based skin adhesives and topical, dermatological products, anti-static products. The Company’s divisions are Aqua Based Technologies, Pros-Aide, and Antistatic Industries. It subsidiaries are Sonotron Medical Systems, Inc. and Pegasus Laboratories.
ADM Tronics Unlimited specializes in electronic medical device design, development and manufacturing for diagnostic and therapeutic medical technologies at its FDA-Registered Medical Device Manufacturing Facility. It is a one-stop source for total design, engineering, regulatory and manufacturing services. In addition to its contract medical device design, engineering and manufacturing services, the Company has several proprietary medical devices. These proprietary devices include therapeutic and diagnostic medical technologies in fields as different as audiology, physical medicine, wound therapy, neurology and urology.
In September 2014, ADM Tronics Unlimited announced that it entered into an affiliation with Triotech Ventures, a technology consortium headquartered in Cambridge, Massachusetts, founded by Dr. Gianluca DeNovi, a recently appointed member of ADM Tronics’ Advisory Board. Triotech’s mission is to support foreign medical technology companies with specialized services and finances to help such companies to access the North American marketplace via a U.S.-based subsidiary.
This past October, ADM Tronics Unlimited announced that S. Vincent Grasso, DO, MSIS, MBA joined the company as Chief Medical Information Officer (CMIO). Dr. Grasso is a surgeon, software architect/informaticist and business strategist. He has more than 20 years of delivering professional services within the global healthcare marketplace.
ADM Tronics Unlimited, Inc. (ADMT), closed Thursday's trading session at $0.22, up 5.01%, on 62,500 volume with 3 trades. The average volume for the last 60 days is 60,185 and the stock's 52-week low/high is $0.016/$0.249.
Elite Pharmaceuticals, Inc. (ELTP)
Top Stock Picks, Stock Analyzer, PennyStocks24, Pumps and Dumps, Planet Penny Stocks, Buzz Stocks, PennyStockProphet, Penny Pick Finders, StockOnion, SecretStockPromo, Capital Equity Report, OTCBB Journal, First Penny Picks, StocksImpossible, and TheMicrocapNews reported earlier on Elite Pharmaceuticals, Inc. (ELTP), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Elite Pharmaceuticals, Inc. develops oral sustained and controlled release products. The Northvale, New Jersey based Company also provides contract manufacturing for Ascend Laboratories (a subsidiary of Alkem Laboratories Ltd.). Additionally, it has partnered with Epic Pharma for the manufacturing and distribution of 11 approved products pending manufacturing site, with Hi-Tech Pharmacal to develop an intermediate for a generic product, and a Hong Kong based company to develop a branded product for the U.S. market and its territories. Elite Pharmaceuticals operates a GMP and DEA registered facility for research, development, and manufacturing located in Northvale. The Company lists on the OTCQB.
Elite Pharmaceuticals has eight commercial products currently selling, 11 approved products pending manufacturing site transfer, and two additional products under review pending approval by the Food and Drug Administration (FDA). Its lead pipeline products include abuse resistant opioids using the Company’s patented proprietary technology, and a once-daily opioid. They are sustained release oral formulations of opioids for the treatment of chronic pain, which address two of the limitations of existing oral opioids: the provision of consistent relief of baseline pain levels and deterrence of potential abuse.
Elite announced in July 2014 the first dosing of a pivotal bioequivalence study in healthy volunteers for ELI-201. This is the Company’s twice daily abuse deterrent oxycodone/naltrexone product, using Elite's proprietary pharmacological abuse deterrent technology. The study is an open-label, single-dose, partially-randomized crossover study in healthy adult subjects.
The primary objective of this study is to compare the bioavailability and establish bioequivalence of ELI-201 controlled-release capsules, 40 mg to OxyContin® controlled-release tablet, 40 mg. The secondary objectives include determining the bioavailability of oxycodone from ELI-201 under fasted and fed conditions and evaluating the safety and tolerability of ELI-201.
Last month, Elite announced successful results from the pivotal bioequivalence (BE) study for ELI-201. The study (initiated in July 2014) demonstrated the Company’s product is bioequivalent to the branded drug based on pharmacokinetic measures. This includes peak concentration (Cmax) and area under the curve (AUC) as measured for opioid blood plasma levels. The study was a single dose, open label, randomized, cross-over study in healthy volunteers with 34 subjects conducted under fasted conditions. Final findings of bioequivalence are dependent upon FDA review.
This month, Elite Pharmaceuticals announced the first shipments of generic Isradipine 2.5 mg and 5.0 mg capsules. Isradipine is a calcium channel blocker prescribed for hypertension. Isradipine is one of the twelve products that Elite Pharmaceuticals acquired from Mikah Pharma and which Elite licensed to Epic Pharma in 2014.
Elite Pharmaceuticals, Inc. (ELTP), closed Thursday's trading session at $0.252, up 17.76%, on 3,450,577 volume with 486 trades. The average volume for the last 60 days is 593,502 and the stock's 52-week low/high is $0.1745/$0.97.
One World Holdings, Inc. (OWOO)
The QualityStocks Daily Newsletter would like to spotlight One World Holdings, Inc. (OWOO). Today, One World Holdings, Inc. closed trading at $0.003, off by 11.76%, on 3,841,000 volume with 37 trades. The stock’s average daily volume over the past 60 days is 3,915,027, and its 52-week low/high is $0.0008/$0.30.
One World Holdings, Inc. subsidiary, The One World Doll Project, announced today it has launched a line of apparel and accessories to expand the Prettie Girls! brand through the company's new direct retail website, oneworlddollshop.com. "Since our 2014 appearance at Toy Fair, we have made tremendous strides towards expanding the recognition and popularity of The Prettie Girls! brand and now that major retailers across the country are taking notice our customer base continues to rapidly grow," said Trent T. Daniel, Founder of The One World Doll Project.
One World Holdings, Inc. (OWOO) subsidiary, The One World Doll Project, was established in 2010 to make a significant positive cultural impact through the doll category, transcending global and ethnic borders to create positive self-image in young women and girl around the world. Led by worldwide famous doll designer Stacy McBride-Irby, The One World Doll Project team has more than 50 collective years in the doll and toy industry and is dedicated and armed with the experience to ensure that the dolls are of the highest quality and value.
In 2013, the company released its Prettie Girls!™ line of multi-cultural fashion dolls uniquely designed with individual physical attributes, personal stories and hobbies, and goals and inspirations. For young girls, the dolls are a friend, a partner in play, and a glimpse of their biggest, brightest dreams. For young women, the dolls are a symbol of who they are and what they can achieve. For doll connoisseurs, The One World Doll Project promises stylish works of art that will become a vital part of a growing collectors’ market.
The One World Doll Project also has a Signature Celebrity Collection of Prettie Girls! and in 2013 released its first celebrity collectors doll modeled after supermodel Cynthia Bailey from The Real Housewives of Atlanta. Since the release of the doll, it has been showcased with Synthia on The Arsenio Hall Show, What Happens Live with Andy Cohen and The Bethenny Show.
Using a web-based sales model, One World Holdings plans to quickly capture significant market share in the dolls and stuffed toys space. After securing a strong online presence, the company will focus on brick and mortar retailing as it moves toward the ultimate pursuit of expanding worldwide. The company has established distribution deals with Toys “R” Us, HEB, dollgenie.com, Tuckers Toy Shop, pattycakedoll.com, and has recently expanded its retail presence internationally with the People’s Pharmacy storechain in the Central American country of Belize. The Prettie Girls! Dolls have been featured in national and international media spotlights like CNN, The Wall Street Journal, Jet Magazine, Bloomberg.com, Parade.com, Dolls Magazine, The Toy Book, The Houston Chronicle and Houston Business Journal, and TheStreet.com. Disclaimer
One World Holdings, Inc. Company Blog
One World Holdings, Inc. News:
As Prettie Girls! Customer Base Grows, the One World Doll Project Begins Product Line Expansion
Vivica A. Fox Talks About Her Collaboration With The One World Doll Project
The One World Doll Project to Release Collectors Doll With Vivica A. Fox
Boreal Water Collection, Inc. (BRWC)
The QualityStocks Daily Newsletter would like to spotlight Boreal Water Collection, Inc. (BRWC). Today, Boreal Water Collection, Inc. closed trading at $0.0025, up 19.05%, on 2,343,955 volume with 13 trades. The stock’s average daily volume over the past 60 days is 1,085,080, and its 52-week low/high is $0.002/$0.03.
Boreal Water Collection, Inc. (BRWC) is an established water bottler of premium private-labeled bottled water products tailored for each client’s particular need, be it publicity, promotion, marketing, internal use or a specific event. This emphasis on customization and quality has earned Boreal an impressive reputation, evidenced by its prestigious customer base of high-end beverage brands, retailer channels, high-end hotels and restaurant chains such as H&M, Mercedes, W Hotels, Dean & Deluca, Fred Water, Wat-aah, Saks Fifth Ave, Balance Water, NY Quin Hotel, Bouchon Bakery and Princeton University, just to name a few!
Located 90 miles north New York City, Boreal’s plant is only 17 miles from its well-protected source of natural spring water, a pristine and abundant spring source deep inside the heart of the Catskill Mountains. The spring’s exceptional geological and geographical features have created the perfect environment for Boreal’s low-mineral, sodium-free and well-balanced PH water. With exclusive exploitation rights, Boreal has a confirmed volume in excess of thousands of millions of gallons.
Boreal offers a line of award-winning water products, including functional enhanced water, infused water, carbonated water, vitamins enhanced water, flavored still or sparkling, minerals enhanced water, oxygenated water, electrolyte water, distilled water, alkaline water, caffeinated water and natural spring water.
Accommodating this plentiful water supply and range of product offerings, Boreal has established a 75,000-square foot manufacturing facility. Boreal can process a full range of water and bottle types and has the most creative staff for all private labeling needs. The company offers fully integrated turnkey service, made-to-order labeling along with distinctive water bottles. In short, Boreal is a “Boutique Bottler” and is focusing on becoming the leader of this attractive niche of the growing multi-billion dollar bottled water industry. Disclaimer
Boreal Water Collection, Inc. Company Blog
Boreal Water Collection, Inc. News:
Boreal Water Collection to Exhibit at China's Largest Food Show
Boreal Water Collection Reports Continued Growth in the Third Quarter of 2014, Sales Increase by 14% While Profitability Rises by 57%
The Chatwal Hotel (NY) Agrees to Have Boreal Water Collection Produce Their Private Labeled Bottled Water
Sibling Group Holdings, Inc. (SIBE)
The QualityStocks Daily Newsletter would like to spotlight Sibling Group Holdings, Inc. (SIBE). Today, Sibling Group Holdings, Inc. closed trading at $0.11, up 14.35%, on 133,874 volume with 20 trades. The stock’s average daily volume over the past 60 days is 74,873, and its 52-week low/high is $0.0571/$0.24.
Sibling Group Holdings, Inc. (SIBE) is enhancing and delivering 21st century learning with advanced technology and education management operations. Accessing funds from the public capital markets is part of the company’s unified strategy to accelerate the improvement of Pre-K, K-12 and post-secondary education around the world. Better educated children and adults, sustainable and cost effective instructional models, and reduced dependence on governmental funding are the end results.
Existing offerings include professional development for the teaching profession; educational technology, including classroom management tools; a comprehensive and flexible online curriculum; an aggregation platform for massive open online courses, and academic and skills credentialing. Investments are being made in specialized curriculum such as STEM (science, technology, engineering and math), ESL (english as a second language), SEL (social and emotional learning), and Special Ed aimed at supporting students with special needs and their teachers.
Sibling Group is acquiring various Ed-tech businesses and components with the goal of building the first complete solution for the delivery and management of educational content, and tracking educational results, in the digital media – from curriculum to course certification. The recent acquisition of Blended Schools Network (BSN), which serves over 160 school districts with 300,000 course enrollments and currently offers 212 different online courses, is a great example and has provided Sibling Group with extensive infrastructure and solid groundwork for growth in a rapidly growing industry.
IBIS Capital is forecasting fifteen-fold growth in the e-learning market over the next 10 years and has even suggested that under certain circumstances the transition to digital education may be quicker and more disruptive than ever observed in the media industry. With a strong, highly experienced management team, Sibling Group is in a unique position to continue expanding its portfolio through additional acquisitions and fundamental growth. Disclaimer
Sibling Group Holdings, Inc. Company Blog
Sibling Group Holdings, Inc. News:
Sibling Group Holdings, Inc. Interviewed by TheStockRadio.com
Sibling Group's Blended Schools Network Partners With BloomBoard, Inc. for Teacher Professional Development
Sibling Group to Acquire Urban Planet Mobile™ -- Leading Global Innovator of Educational Products
Save The World Air, Inc. (ZERO)
The QualityStocks Daily Newsletter would like to spotlight Save The World Air, Inc. (ZERO). Today, Save The World Air, Inc. closed trading at $0.42, even for the day, on 152,693 volume with 36 trades. The stock’s average daily volume over the past 60 days is 110,102, and its 52-week low/high is $0.3401/$1.10.
Save The World Air, Inc. (ZERO) (“STWA”) provides the global energy industry with patent-protected industrial equipment designed to deliver measurable performance improvements to crude oil pipelines. Developed in partnership with leading crude oil production and transportation entities, STWA’s high-value solutions address the enormous capacity inadequacies of domestic and overseas pipeline infrastructures that were designed and constructed prior to the current worldwide surge in oil production.
In support of our clients’ commitment to the responsible sourcing of energy and environmental stewardship, STWA combines scientific research with inventive problem solving to provide energy efficiency ‘clean tech’ solutions to bring new efficiencies and lower operational costs to the upstream, midstream and gathering sectors. STWA’s flagship product, AOT (Applied Oil Technology) improves the economics of transporting crude oil by reducing the viscosity of oil in pipelines. Once deployed on pipeline pumping stations, production and transportation companies benefit from the safer, more cost-effective delivery of greater volumes of oil while reducing energy consumption at pumping stations and lowering CO2 emissions.
The AOT technology is the result of years of research conducted at Temple University (Philadelphia, Penn.) and is the world’s first ASME-certified industrial hardware to use the principles of electrorheology, the study of applying non-uniform electrical fields to change the mechanical behavior of fluids, to significantly reduce the viscosity of crude oil within pipelines during maximum flow conditions. Field tested by the U.S. Department of Energy, independent testing laboratories such as ATS RheoSystems and fabricated to exacting industry standards by STWA’s supply chain partners, the efficacy of AOT to increase flow rates, prevent bottlenecks, reduce pump station power consumption, enhance pipeline integrity and optimize flow assurance has been proven repeatedly in the lab and on a 300,000 barrel per day pipeline.
STWA is also commercializing STWA Joule Heat, an energy-efficient technology for heating crude oil in pipelines to improve flow. Unlike traditional trace heating systems which generate heat via a resistive trace heating element which transfers energy into the oil, the STWA solution applies an electrical field directly to oil, generating heat within the flow itself. The result is optimal heat conductivity and performance with less power and in a smaller form factor.
Guided by a dynamic management team led by Greggory Bigger, Chief Executive Officer, Chairman and a strong independent board of directors of energy industry veterans, STWA is a revenue generating company with a solid cash position, clean balance sheet and a proven ability to develop and deliver industrial-grade equipment that support the company’s mission and enhance shareholder value. As the exclusive licensee of oil viscosity reduction processes developed at Temple University and owner of 48 worldwide patents related to the use of electricity to change the mechanical behavior of oil and liquid natural gas, STWA is well-positioned to capitalize on the explosive growth opportunities in the global crude oil production and transportation sector. More information is available at: www.stwa.com. Disclaimer
Save The World Air, Inc. Company Blog
Save The World Air, Inc. News:
STWA Appoints Energy Industry Executive Thomas A. Bundros to Board of Directors
STWA Issues Letter to Shareholders
STWA Upgrades to OTCQX(R) Marketplace
Well Power Inc. (WPWR)
The QualityStocks Daily Newsletter would like to spotlight Well Power Inc. (WPWR). Today, Well Power Inc. closed trading at $0.0385, up 4.05%, on 74,608 volume with 9 trades. The stock’s average daily volume over the past 60 days is 109,506, and its 52-week low/high is $0.03/$2.00.
Well Power Inc. (WPWR) has secured the licensing rights to Texas with the first right of refusal on the other US states to a new technology solution to process waste natural gas, such as vented, flared or stranded gas, into “clean power” and engineered fuels, including no-sulphur diesel and diluents. Based on proprietary technology, this solution is mobile, high-yield and can be deployed with minimum capital expenditure.
The company plans to be able to provide its technology with full-service engineering, design, construction, modular fabrication, maintenance and construction management services to clients in the upstream areas of exploration and production. Well Power will also offer consulting services, process assessments, facility appraisals, feasibility studies, technology evaluations, project finance structuring and support, and multi-client subscription services.
Approximately 2.4 million barrels of oil equivalent is wasted each day by gas flaring alone, resulting in $10 billion of lost revenue and 400 million metric tons of CO2 equivalent global greenhouse gas emissions each year. Additionally, environmental degradation associated with gas flaring has been shown to have a significant impact on local populations, often resulting in loss of livelihood and severe health issues.
Well Power’s Micro Refinery Unit (MRU) offers the opportunity to create value from a wasted resource while simultaneously enabling wider access to energy, improved environmental conditions, and economic development for local populations. By eliminating legacy flaring and minimizing new flaring, the company is well positioned to take a leadership role in the ongoing push for sustainable resource development and energy efficiency. Disclaimer
Well Power Inc. Company Blog
Well Power Inc. News:
Well Power - Letter from President to Shareholders
Well Power Inc. to host second webinar on proprietory micro-refinery technology
Well Power Inc. Information to be Available through S&P Capital IQ Corporation Records Program
Zenosense, Inc. (ZENO)
The QualityStocks Daily Newsletter would like to spotlight Zenosense, Inc. (ZENO). Today, Zenosense, Inc. closed trading at $0.221, up 0.45%, on 6,768 volume with 6 trades. The stock’s average daily volume over the past 60 days is 144,358, and its 52-week low/high is $0.15/$1.00.
Zenosense, Inc. (ZENO) is developing and intends to market a novel device to enable hospitals to detect Methicillin-resistant Staphylococcus Aureus (MRSA) bacterial contamination, a major constituent of Hospital Acquired Infections (HAIs). The annual costs of treating hospitalized MRSA patients are estimated to be between $3.2 billion and $4.2 billion in the United States alone. MRSA infected patients are likely to spend three times as long in a hospital stay at three times the cost, and are five times more likely to die than an uninfected patient.
Early detection of MRSA and HAIs in general is vital. Recent studies suggest that implementing prevention practices can lead to up to a 70 percent reduction in certain HAIs with a financial benefit of using these prevention practices estimated to be as high as $25.0 billion to $31.5 billion in medical cost savings in the United States alone (according to a report by the Centers for Disease Control and Prevention, part of the US Department of Health and Human Sciences). Currently, no cost effective early detection device is available.
The Zenosense MRSA detection device is expected to act like a “smoke detector” for MRSA; designed to detect MRSA in the environment or infected patient, even before a patient demonstrates any obvious symptoms, satisfying this huge unmet need.
Zenosense has an agreement with leading European sensor developer Sgenia Group, which is developing such a device exclusively for Zenosense through their subsidiary Zenon Biosystem. The estimated manufacturing cost per device is under $100 USD and possibly as low as $50 USD. The Zenosense device, utilizing established Sgenia programming and patent-pending hardware, utilizes a single sensor to perform an infinite number of scans, creating tens of thousands of "virtual sensors". The low cost and compact design of the Zenosense device, if successfully developed, would make it possible to be worn by individuals, as well as placed in numerous sensitive areas in the healthcare setting.
Zenosense has a streamlined management team experienced in high-level marketing in the medical sector, supported by the outsourced Zenon Biosystem scientific/development team of qualified personnel with extensive knowledge and experience in the development of sensors. Both of these teams will fuse together through a high level advisory board of experienced professionals. A cost-effective Zenosense MRSA detection device, once developed, is expected to be in high demand, driven by patient safety, cost and insurance considerations. Disclaimer
Zenosense, Inc. Company Blog
Zenosense, Inc. News:
Zenosense, Inc. - Hospital Collaboration - 400 Person Lung Cancer Detection Trial
Zenosense, Inc.; Stock Now DTC DWAC/FAST Eligible
Zenosense, Inc. Reports Manufacturing of Pre-Commercial Lung Cancer Detection Device
VistaGen Therapeutics, Inc. (VSTA)
The QualityStocks Daily Newsletter would like to spotlight VistaGen Therapeutics, Inc. (VSTA). Today, VistaGen Therapeutics, Inc. closed trading at $8.00, even with yesterday's close. The stock’s average daily volume over the past 60 days is 225, and its 52-week low/high is $5.508/$15.00.
VistaGen Therapeutics, Inc. (VSTA) is a biotechnology company applying stem cell technology for drug rescue and cell therapy. Drug rescue combines human stem cell technology with modern medicinal chemistry to generate new chemical variants ("drug rescue variants") of once-promising drug candidates that have been discontinued during late-stage preclinical development due to heart or liver safety concerns. VistaGen also focuses on cell therapy, or regenerative medicine, which includes repairing, replacing or restoring damaged tissues or organs
VistaGen's versatile stem cell technology platform, Human Clinical Trials in a Test Tube™, has been developed to provide clinically relevant predictions of potential heart and liver toxicity of promising new drug candidates long before they are ever tested on humans.
By more closely approximating human biology than conventional animal studies and other nonclinical techniques and technologies currently used in drug development, VistaGen's human stem cell-based bioassay systems can improve the predictability of the drug development cycle and lower the cost of new drug research and development by identifying product failures earlier in the cost curve. According to the Food and Drug Administration even only a ten percent improvement in predicting failure before clinical trials could save $100 million in development costs, which savings ultimately could be passed on to patients.
Using mature human heart cells produced from stem cells, VistaGen has developed and internally validated CardioSafe 3D™, a novel three-dimensional (3D) bioassay system for predicting the in vivo cardiac effects of new drug candidates before they are tested in humans. VistaGen is now focused on using CardioSafe 3D™ to generate up to two new, safer small molecule drug rescue variants every twelve to eighteen months. VistaGen anticipates that these drug rescue variants will be modified versions of once-promising new drug candidates that have been discontinued by pharmaceutical companies and academic research institutions because of heart toxicity concerns, despite substantial prior investment and positive efficacy data demonstrating their potential therapeutic and commercial benefits. In most cases, VistaGen plans to license or sell its new, safer drug rescue variants in strategic partnering arrangements with global pharmaceutical companies, arrangements providing VistaGen with both near term and downstream milestone payments and economic participation rights but without future development cost obligations.
AV-101, VistaGen's lead small molecule prodrug candidate, has successfully completed Phase I clinical development in the U.S. for treatment of neuropathic pain, a serious and chronic condition affecting millions of people worldwide, depression, and other neurological diseases and conditions. To date, the U.S. National Institutes of Health (NIH) has awarded VistaGen over $8.75 million for development of AV-101. Management anticipates strategically out-licensing AV-101 to a development and marketing partner in 2013.
VistaGen is also developing LiverSafe 3D™, a novel predictive liver toxicity and drug metabolism bioassay system for drug rescue applications. In parallel with drug rescue activities, the Company is funding early-stage nonclinical studies focused on potential cell therapy applications of its Human Clinical Trials in a Test Tube™ platform. Disclaimer
VistaGen Therapeutics, Inc. Company Blog
VistaGen Therapeutics, Inc. News:
VistaGen Signs Letter of Intent With National Institute of Mental Health for NIH-Sponsored Phase 2 Clinical Study of AV-101 in Major Depressive Disorder
VistaGen Receives Notice of Allowance for Canadian Patent, Further Expanding Stem Cell Technology Platform
VistaGen Announces Reverse Stock Split
Today's Top 3
Wall Street Resources
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Boreal Water Collection, Inc. (BRWC) to Exhibit at China's Largest Food Show
- Cleartronic, Inc. (CLRI) Appoints Two New Members to Board of Directors
- Coastal Integrated Services, Inc. (COLV) Announces Engagement of QualityStocks Investor Relations Services
- Consorteum Holdings, Inc. (CSRH) Signs License Agreement With NYG Holdings
- Dominovas Energy Corp. (DNRG) Key Management Featured in Exclusive QualityStocks Interview
- Falcon Crest Energy (FCEN) Optimistic About Prospecting in Powder River Basin
- IFAN Financial, Inc. (IFAN) Enters Agreement to Provide Development Assistance to Card Collaborative International, LLC
- MIT Holding, Inc. (MITD) Names Tommy J. Duncan as President
- Mobile Lads Corp. (MOBO) Purchases Majority of North American Shopping Network From Domark International
- One World Holdings, Inc. (OWOO) As Prettie Girls! Customer Base Grows, the One World Doll Project Begins Product Line Expansion
- Pan Global Corp. (PGLO) Comments on Industry Report That the India Renewable Energy Market Opportunity Is Worth USD $10.5 Billion by 2017
- Puget Technologies, Inc. (PUGE) Forms Strategic Alliance With RamRock Building Systems
- Pure Hospitality Solutions, Inc. (PNOW) Expands Oveedia, Aligns With Sabre Travel Network
- Save The World Air, Inc. (ZERO) Issues Letter to Shareholders
- Sibling Group Holdings, Inc. (SIBE) Interviewed by TheStockRadio.com
- Sparta Commercial Services, Inc. (SRCO) iMobileApp's Customer Base Continues to Grow and Broaden
- Start Scientific, Inc. (STSC) Signs Farmout Agreement With Durban Energy
- VistaGen Therapeutics, Inc. (VSTA) Signs Letter of Intent With National Institute of Mental Health for NIH-Sponsored Phase 2 Clinical Study of AV-101 in Major Depressive Disorder
- Well Power Inc. (WPWR) to host second webinar on proprietory micro-refinery technology
- WordLogic Corp. (WLGC) Inks Deal to Monetize Intellectual Property for General Electric (GE)
- Zenosense, Inc. (ZENO) Hospital Collaboration - 400 Person Lung Cancer Detection Trial